A multicenter Phase II trial of gefitinib 500 mg/day in 192 patients with advanced epidermal growth factor receptor-positive solid tumors who had failed previous chemotherapy.
(2005)
Files
No attached file found for this publication.
Details
- Authors
- Affiliations
Citations
Vergote, I., Humblet, Y., Van Cutsem, E., Van Belle, S., Kerger, J., Van Laethem, J., Canon, J., Forget, F., Amant, F., & Van Oosterom, A. (2005). A multicenter Phase II trial of gefitinib 500 mg/day in 192 patients with advanced epidermal growth factor receptor-positive solid tumors who had failed previous chemotherapy. EJC - Supplements, 3(2), 423. (Original work published 2005)